Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_assertion type Assertion NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_head.
- NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_assertion description "[FTL is an inflammation marker also implicated in cancer, S100A9 is an important member of the Ca(2+) signaling cascade reported to be altered in GBM tissue, and CNDP1 has been reported for its role in the regulation of the levels of carnosine, implicated as a potential drug for GBM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_provenance.
- NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_assertion evidence source_evidence_literature NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_provenance.
- NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_assertion SIO_000772 23029420 NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_provenance.
- NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_assertion wasDerivedFrom befree-20140225 NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_provenance.
- NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_assertion wasGeneratedBy ECO_0000203 NP404773.RA68VGQUjYIdIrdsRA67gzCmLBAvkD48TMFSBGHoxR9QE130_provenance.